Exelixis, Inc. (EXEL): Price and Financial Metrics
Exelixis, Inc. (EXEL)
Today's Latest Price: $19.41 USD
0.68 (3.63%)
Updated Nov 27 1:00pm
Add EXEL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
EXEL Stock Summary
- The ratio of debt to operating expenses for Exelixis Inc is higher than it is for about merely 9.07% of US stocks.
- EXEL's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 9.94% of US stocks.
- With a year-over-year growth in debt of 100.91%, Exelixis Inc's debt growth rate surpasses 88.18% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Exelixis Inc, a group of peers worth examining would be GNTX, MYOV, CKPT, RARE, and HRTX.
- EXEL's SEC filings can be seen here. And to visit Exelixis Inc's official web site, go to www.exelixis.com.
EXEL Stock Price Chart Interactive Chart >
EXEL Price/Volume Stats
| Current price | $19.41 | 52-week high | $27.80 |
| Prev. close | $18.73 | 52-week low | $13.67 |
| Day low | $18.52 | Volume | 1,739,955 |
| Day high | $19.47 | Avg. volume | 2,920,189 |
| 50-day MA | $22.12 | Dividend yield | N/A |
| 200-day MA | $22.06 | Market Cap | 6.02B |
Exelixis, Inc. (EXEL) Company Bio
Exelixis is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. The company was founded in 1994 and is based in San Francisco, California.
Loading social stream, please wait...